SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Justin S. Becker, Dario Nicetto, Kenneth S. Zaret, H3K9me3-Dependent Heterochromatin: Barrier to Cell Fate Changes, Trends in Genetics, 2016, 32, 1, 29

    CrossRef

  2. 2
    Federico González, Danwei Huangfu, Mechanisms underlying the formation of induced pluripotent stem cells, Wiley Interdisciplinary Reviews: Developmental Biology, 2016, 5, 1
  3. 3
    Yan Xu, Meng Zhang, Wenjuan Li, Xihua Zhu, Xichen Bao, Baoming Qin, Andrew P. Hutchins, Miguel A. Esteban, Transcriptional Control of Somatic Cell Reprogramming, Trends in Cell Biology, 2016,

    CrossRef

  4. 4
    Daniele Focosi, Fabrizio Maggi, Luca Ceccherini-Nelli, Mauro Pistello, Cell therapies for treatment of human immunodeficiency virus infection, Reviews in Medical Virology, 2015, 25, 3
  5. 5
    Clara Lopes Novo, Peter J. Rugg-Gunn, Chromatin organization in pluripotent cells: emerging approaches to study and disrupt function, Briefings in Functional Genomics, 2015, elv029

    CrossRef

  6. 6
    Yang Yu, Liang Chang, Hongcui Zhao, Rong Li, Yong Fan, Jie Qiao, Chromosome microduplication in somatic cells decreases the genetic stability of human reprogrammed somatic cells and results in pluripotent stem cells, Scientific Reports, 2015, 5, 10114

    CrossRef

  7. 7
    Sarita S. Paranjpe, Gert Jan C. Veenstra, Establishing pluripotency in early development, Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms, 2015, 1849, 6, 626

    CrossRef

  8. 8
    Behnam Ebrahimi, Reprogramming barriers and enhancers: strategies to enhance the efficiency and kinetics of induced pluripotency, Cell Regeneration, 2015, 4, 1

    CrossRef

  9. 9
    Jeannine Basta, Michael Rauchman, The nucleosome remodeling and deacetylase complex in development and disease, Translational Research, 2015, 165, 1, 36

    CrossRef

  10. 10
    Chen Yu, Kai Liu, Shibing Tang, Sheng Ding, Chemical approaches to cell reprogramming, Current Opinion in Genetics & Development, 2014, 28, 50

    CrossRef

  11. 11
    Anne Laugesen, Kristian Helin, Chromatin Repressive Complexes in Stem Cells, Development, and Cancer, Cell Stem Cell, 2014, 14, 6, 735

    CrossRef

  12. 12
    Huen Suk Kim, Jeffrey M. Bernitz, Dung-Fang Lee, Ihor R. Lemischka, Genomic Editing Tools to Model Human Diseases with Isogenic Pluripotent Stem Cells, Stem Cells and Development, 2014, 23, 22, 2673

    CrossRef

  13. 13
    Sabine Gerbal-Chaloin, Natalie Funakoshi, Amandine Caillaud, Claire Gondeau, Benoite Champon, Karim Si-Tayeb, Human Induced Pluripotent Stem Cells in Hepatology, The American Journal of Pathology, 2014, 184, 2, 332

    CrossRef

  14. 14
    E. V. Novosadova, I. A. Grivennikov, Induced pluripotent stem cells: From derivation to application in biochemical and biomedical research, Biochemistry (Moscow), 2014, 79, 13, 1425

    CrossRef

  15. 15
    Roberta Menafra, Hendrik G. Stunnenberg, MBD2 and MBD3: elusive functions and mechanisms, Frontiers in Genetics, 2014, 5,

    CrossRef

  16. 16
    Rodrigo L. dos Santos, Luca Tosti, Aliaksandra Radzisheuskaya, Isabel M. Caballero, Keisuke Kaji, Brian Hendrich, José C.R. Silva, MBD3/NuRD Facilitates Induction of Pluripotency in a Context-Dependent Manner, Cell Stem Cell, 2014, 15, 1, 102

    CrossRef

  17. 17
    Abdenour Soufi, Mechanisms for enhancing cellular reprogramming, Current Opinion in Genetics & Development, 2014, 25, 101

    CrossRef

  18. 18
    Carissa Dege, James Hagman, Mi-2/NuRD chromatin remodeling complexes regulate B and T-lymphocyte development and function, Immunological Reviews, 2014, 261, 1
  19. 19
    Shangqin Guo, Xiaoyuan Zi, Vincent P. Schulz, Jijun Cheng, Mei Zhong, Sebastian H.J. Koochaki, Cynthia M. Megyola, Xinghua Pan, Kartoosh Heydari, Sherman M. Weissman, Patrick G. Gallagher, Diane S. Krause, Rong Fan, Jun Lu, Nonstochastic Reprogramming from a Privileged Somatic Cell State, Cell, 2014, 156, 4, 649

    CrossRef

  20. 20
    Laurent David, Jose M. Polo, Phases of reprogramming, Stem Cell Research, 2014, 12, 3, 754

    CrossRef

  21. 21
    Bor L. Tang, Stress and pluripotency, Frontiers in Cell and Developmental Biology, 2014, 2,

    CrossRef

  22. 22
    Hui Ma, Jin Rong Ow, Bobby Cheng Peow Tan, Ziyi Goh, Bo Feng, Yuin Han Loh, Monica Fedele, Hu Li, Qiang Wu, The dosage of Patz1 modulates reprogramming process, Scientific Reports, 2014, 4, 7519

    CrossRef

  23. 23
    Xin Huang, Jianlong Wang, The extended pluripotency protein interactome and its links to reprogramming, Current Opinion in Genetics & Development, 2014, 28, 16

    CrossRef

  24. 24
    Kathleen A. Worringer, Tim A. Rand, Yohei Hayashi, Salma Sami, Kazutoshi Takahashi, Koji Tanabe, Megumi Narita, Deepak Srivastava, Shinya Yamanaka, The let-7/LIN-41 Pathway Regulates Reprogramming to Human Induced Pluripotent Stem Cells by Controlling Expression of Prodifferentiation Genes, Cell Stem Cell, 2014, 14, 1, 40

    CrossRef

  25. 25
    Effie Apostolou, Konrad Hochedlinger, Chromatin dynamics during cellular reprogramming, Nature, 2013, 502, 7472, 462

    CrossRef

  26. 26
    Yoach Rais, Asaf Zviran, Shay Geula, Ohad Gafni, Elad Chomsky, Sergey Viukov, Abed AlFatah Mansour, Inbal Caspi, Vladislav Krupalnik, Mirie Zerbib, Itay Maza, Nofar Mor, Dror Baran, Leehee Weinberger, Diego A. Jaitin, David Lara-Astiaso, Ronnie Blecher-Gonen, Zohar Shipony, Zohar Mukamel, Tzachi Hagai, Shlomit Gilad, Daniela Amann-Zalcenstein, Amos Tanay, Ido Amit, Noa Novershtern, Jacob H. Hanna, Deterministic direct reprogramming of somatic cells to pluripotency, Nature, 2013, 502, 7469, 65

    CrossRef

  27. 27
    Justin Brumbaugh, Konrad Hochedlinger, Removing Reprogramming Roadblocks: Mbd3 Depletion Allows Deterministic iPSC Generation, Cell Stem Cell, 2013, 13, 4, 379

    CrossRef

  28. 28
    Kyle M. Loh, Bing Lim, Stem cells: Close encounters with full potential, Nature, 2013, 502, 7469, 41

    CrossRef

  29. 29
    Boon Chin Heng, Martin Fussenegger, The Synthetic Biology Approach to Stem Cells and Regenerative Medicine, Reviews in Cell Biology and Molecular Medicine,